Home > Insider Trading > Filing (0001019056-19-000476)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1671584	Aptevo Therapeutics Inc.	APVO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1380185	Fuad El-Hibri	2401 4Th Avenue, Suite 1050 Seattle WA 98121		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-08-12	100,000	$0.76	1,124,536	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,172,125	Indirect	By Intervac, L.L.C.
Common Stock	762,077	Indirect	By Biovac, L.L.C.

Footnotes

The transaction reported on this Form 4 was made by the Reporting Person pursuant to a trading plan adopted on May 31, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
The price reported represents the weighted average price of shares purchased in multiple transactions at prices ranging from $0.4999 to $0.8000 per share. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
The Reporting Person's wife, individually, and the Reporting Person and his wife, as tenants by the entirety, collectively hold an aggregate 40.65% equity interest in Intervac, L.L.C., a Maryland limited liability company, which in turn beneficially owns an aggregate of 2,172,125 shares of common stock. The Reporting Person expressly disclaims beneficial ownership of any shares of common stock owned by Intervac, L.L.C., except to the extent of his pecuniary interest therein.
The Reporting Person holds individually and with his wife, as tenants by the entirety, an aggregate 89.2% equity interest in Biovac, L.L.C. Biovac, L.L.C. is the direct owner of 762,077 shares of common stock. The Reporting Person disclaims beneficial ownership of the shares of common stock directly owned by Biovac, L.L.C., except to the extent of his pecuniary interest therein.